Susquehanna International Group
MITO

Susquehanna International Group’s Stealth BioTherapeutics Corp. ADS MITO Stock Holding History

Susquehanna International Group’s Portfolio MITO Stock Details MITO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-30,991
Closed -$10K – 14538
2022
Q3 		$10K Sell
30,991
-23,183
-43% -$6.6K ﹤0.01% 12788
2022
Q2 		$14K Buy
+54,174
New +$18.6K ﹤0.01% 12447
2021
Q1 		– Sell
-27,282
Closed -$41K – 13060
2020
Q4 		$41K Buy
+27,282
New +$38.3K ﹤0.01% 10796

Susquehanna International Group's MITO Position: Q4 2022 in Review

Susquehanna International Group sold out of Stealth BioTherapeutics Corp. ADS (MITO) in Q4 2022, closing a stake of 30,991 shares — an estimated $10K sold.

Susquehanna International Group first reported a position in MITO in Q4 2020 and held it in 3 quarters. The position peaked at $41K in Q4 2020. 0 funds tracked by Wall St. Rank hold MITO as of Q4 2022.

  • Susquehanna International Group reported no remaining Stealth BioTherapeutics Corp. ADS position as of Q4 2022 after selling out during the quarter.
  • Susquehanna International Group sold 30,991 Stealth BioTherapeutics Corp. ADS shares in Q4 2022, an estimated $10K.
  • Susquehanna International Group first reported a position in Stealth BioTherapeutics Corp. ADS in Q4 2020 and held it in 3 quarters.
  • Susquehanna International Group's Stealth BioTherapeutics Corp. ADS position peaked at $41K in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Stealth BioTherapeutics Corp. ADS as of Q4 2022.

Based on Susquehanna International Group's 13F filing for Q4 2022, filed 14 Feb 2023.